Charles J. Kroger, Ph.D.

Affiliations: 
2006 Wake Forest University, Winston-Salem, NC, United States 
Area:
Immunology
Google:
"Charles Kroger"

Parents

Sign in to add mentor
Martha A. Alexander-Miller grad student 2006 Wake Forest
 (Regulated CD8 isoform expression as a mechanism to control functional avidity.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ke Q, Kroger CJ, Clark M, et al. (2020) Evolving Antibody Therapies for the Treatment of Type 1 Diabetes. Frontiers in Immunology. 11: 624568
Clark M, Kroger CJ, Ke Q, et al. (2020) The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes. Frontiers in Immunology. 11: 615371
Chen N, Kroger CJ, Tisch RM, et al. (2018) Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31. Advanced Healthcare Materials. e1800341
Kroger CJ, Spidale NA, Wang B, et al. (2016) Thymic Dendritic Cell Subsets Display Distinct Efficiencies and Mechanisms of Intercellular MHC Transfer. Journal of Immunology (Baltimore, Md. : 1950)
Kroger CJ, Wang B, Tisch R. (2016) Temporal increase in thymocyte negative selection parallels enhanced thymic SIRPα(+) DC function. European Journal of Immunology
He Q, Morillon YM, Spidale NA, et al. (2013) Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner. Journal of Immunology (Baltimore, Md. : 1950). 191: 5858-66
Kroger CJ, Flores RR, Morillon M, et al. (2010) Dysregulation of thymic clonal deletion and the escape of autoreactive T cells. Archivum Immunologiae Et Therapiae Experimentalis. 58: 449-57
Wallet MA, Flores RR, Wang Y, et al. (2009) MerTK regulates thymic selection of autoreactive T cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 4810-5
Kroger CJ, Amoah S, Alexander-Miller MA. (2008) Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen. Journal of Immunology (Baltimore, Md. : 1950). 180: 5784-8
Kroger CJ, Alexander-Miller MA. (2007) Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 748-51
See more...